Astena Holdings Co., Ltd.

Pharmaceutical products are subject to pharmaceutical affairs-related regulations, and poisonous and deleterious substances for non-pharmaceutical use are subject to the Poisonous and Deleterious Substances Control Act. Failure to respond appropriately could result in restrictions on business activities. The Company is building a framework and system capable of responding to legal regulations, and conducts employee training by specialists such as pharmacists as appropriate.

Against a backdrop of intensifying inter-company competition and a harsh economic environment, if a business partner defaults on obligations due to bankruptcy, civil rehabilitation, or similar events, this could affect business performance. The Company conducts periodic assessments, including obtaining credit information from multiple external agencies, to keep the materialization of credit risk within certain limits.

If restructuring such as mergers or integrations among major business partners accelerates, depending on the developments this could affect the Group's sales. To avoid concentration of transactions with specific partners, the Company manages diversification of business partners and transaction content.

In the import and production of various products, unexpected product defects could occur, potentially resulting in exposure to product liability and other obligations. The Company has established a rigorous inspection system based on internally established standards, and the Group as a whole has taken out product liability insurance (PL insurance), building a system to minimize the impact on business performance and financial condition.

Because business activities depend heavily on computer systems, if system trouble, a large-scale disaster, computer virus intrusion, or similar events occur, this could disrupt business activities such as logistics and sales, and affect business performance, financial condition, and social credibility. The Company is working to enhance security functions against unauthorized external intrusion and to ensure backup functions.

There is always the possibility of a large-scale share purchase by a third party that could harm corporate value and the common interests of shareholders, which could have a significant adverse effect on business execution. The Company's policy is to implement countermeasures, while ensuring objectivity and rationality, in the event such risk materializes.

In the course of business activities, the Company could face litigation for damages or other injunctions, and depending on the developments and outcome, this could affect business performance, financial condition, and social credibility. The Company conducts sufficient prior investigation for initiatives where litigation is anticipated, and works to reduce risk by coordinating with retained legal counsel as necessary.

While business expansion in overseas markets is one of the Company's strategies, in addition to foreign exchange risk, obstacles such as political instability, uncertainty in economic trends, legal regulations, and business customs could affect business performance. To address foreign exchange fluctuation risk, the Company utilizes currency-related derivative transactions such as forward foreign exchange contracts, and conducts sufficient prior research on economic trends, legal regulations, and business customs when expanding overseas.

The Company has multiple manufacturing and sales sites both domestically and overseas, and if business activities are suspended due to large-scale natural disasters such as earthquakes and tsunamis, accidents, terrorism, infectious diseases, or similar events, this could affect business performance. The Company has established BCP regulations and has put in place disaster response preparations such as major earthquake manuals and the deployment of safety confirmation systems.

Regarding business assets such as goodwill and intangible assets arising from corporate acquisitions and manufacturing facilities, if expected cash flows cannot be generated due to divergence from business plans, market changes, deterioration in profitability, or similar factors, or if fair value declines significantly, the recognition of impairment losses could affect business performance. Under management that emphasizes efficiency, the Company keeps held assets to a minimum, and also establishes a business execution and management framework after investment to prevent declines in profitability.